Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Account Payables: 2009-2020

Historic Change in Account Payables for Sunshine Biopharma (SBFM) over the last 12 years, with Dec 2020 value amounting to -$35,012.

  • Sunshine Biopharma's Change in Account Payables fell 49.57% to $33,797 in Q4 2019 from the same period last year, while for Dec 2019 it was -$18,692, marking a year-over-year decrease of 130.33%. This contributed to the annual value of -$35,012 for FY2020, which is 87.31% down from last year.
  • Sunshine Biopharma's Change in Account Payables amounted to -$35,012 in FY2020, which was down 87.31% from -$18,692 recorded in FY2019.
  • Sunshine Biopharma's 5-year Change in Account Payables high stood at $61,629 for FY2018, and its period low was -$80,000 during FY2016.
  • Over the past 3 years, Sunshine Biopharma's median Change in Account Payables value was -$18,692 (recorded in 2019), while the average stood at $2,642.
  • Its Change in Account Payables has fluctuated over the past 5 years, first slumped by 199.39% in 2016, then skyrocketed by 799.69% in 2018.
  • Yearly analysis of 5 years shows Sunshine Biopharma's Change in Account Payables stood at -$80,000 in 2016, then soared by 88.99% to -$8,808 in 2017, then skyrocketed by 799.69% to $61,629 in 2018, then crashed by 130.33% to -$18,692 in 2019, then plummeted by 87.31% to -$35,012 in 2020.